As the demand for plasmid DNA (pDNA) based gene therapy and vaccines increases, large-scale, cost-effective, and reproducible pDNA production is.
Electrophoresis Market Size to Reach USD 2436 1 Million by 2026 at CAGR 3 1%
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Advanced Aesthetic Technologies, Inc Announces the Treatment of the First Patient in a Pivotal Clinical Trial in China with their Algeness VL (2 5% Agarose Gel) Filler for the Correction of Moderate to Severe Nasolabial Folds
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
(0)
Results of Split-Face Study to Determine the Efficacy and Safety of 2.5% Agarose Gel Filler for the Correction of Nasolabial Folds Published in Peer Reviewed Journal
BROOKLINE, Mass., May 25, 2021 /PRNewswire/ Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, is proud to announce that Algeness VL (2.5% Agarose Gel) demonstrated equivalent efficacy, safety, and usability compared to those of NASHA-L based on a split-face study published in the Journal of Cosmetic Dermatology. Agarose gel filler is a naturally occurring polymer gel with a three-dimensional structure similar to the extracellular matrix, which achieves its duration without the need for crosslinking. Our objective with this study of 66 patients was to determine the efficacy and safety of 2.5% agarose gel filler for the correction of nasolabial folds as compared with NASHA-L. Our assessments included assessment of the nasolabial fold (NLF), Wrinkle Severity Rating Scale